Discover
RCKT
Rocket Pharmaceuticals, Inc.
3.40
12 x 2.93
1 x 3.88
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | -3.13% | |
| 1y | 0.89% |
3.37
day range
3.40
2.53
52 week range
5.45
| Open | 3.40 | Prev Close | 3.40 | Low | 3.37 | High | 3.40 | Mkt Cap | 371.26M |
| Vol | 26.70K | Avg Vol | 2.49M | EPS | -1.84 | P/E | -1.85 | Forward P/E | -3.35 |
| Beta | 0.45 | Short Ratio | 7.72 | Inst. Own | 106.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.28 | 200-d Avg | 3.59 | 1yr Est | 40.93 |
| Income Statement | |||
| Operating Expenses | 48.51M | ||
| Research and Development Expense | 31.45M | ||
| Selling, General and Administrative Expense | 17.06M | ||
| Operating Income | -48.51M | ||
| Interest Expense | 473.00K | ||
| Net Income | -47.59M | ||
| Net Income Common Stock | -47.59M | ||
| Net Income Common Stock (USD) | -47.59M | ||
| Consolidated Income | -47.59M | ||
| Earnings per Basic Share | -0.42 | ||
| Earnings per Basic Share (USD) | -0.42 | ||
| Earnings per Diluted Share | -0.42 | ||
| Earning Before Interest & Taxes (EBIT) | -47.12M | ||
| Earning Before Interest & Taxes (USD) | -47.12M | ||
| Weighted Average Shares | 112.13M | ||
| Weighted Average Shares Diluted | 112.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 51.43M | ||
| Cash and Equivalents (USD) | 51.43M | ||
| Investments | 94.77M | ||
| Investments Current | 94.77M | ||
| Current Assets | 149.83M | ||
| Property, Plant & Equipment Net | 69.45M | ||
| Total Assets | 285.41M | ||
| Debt Current | 2.92M | ||
| Total Debt | 24.76M | ||
| Current Liabilities | 24.47M | ||
| Debt Non-Current | 21.84M | ||
| Total Liabilities | 47.37M | ||
| Accumulated Retained Earnings (Deficit) | -1.49B | ||
| Accumulated Other Comprehensive Income | -112.00K | ||
| Shareholders Equity | 238.04M | ||
| Shareholders Equity (USD) | 238.04M | ||
| Assets Non-Current | 135.58M | ||
| Total Debt (USD) | 24.76M | ||
| Goodwill and Intangible Assets | 64.30M | ||
| Liabilities Non-Current | 22.90M | ||
| Trade and Non-Trade Payables | 21.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.15M | ||
| Net Cash Flow from Financing | -1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.95M | ||
| Capital Expenditure | -93.00K | ||
| Net Cash Flow from Investing | 17.45M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.54M | ||
| Net Cash Flow from Operations | -45.39M | ||
| Share Based Compensation | 8.49M | ||